Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 28 tags : Trial save search
INDUS Announces Closing on the Acquisition of a 395,000 Square Foot Industrial/Logistics Building in Charlotte, North Carolina
Published: 2021-06-28 (Crawled : 21:00) - globenewswire.com
INDT 4 | $66.99 0.02% 0.0% 0
|
Real Estate and Rental and Leas...
|
| O: 0.59%
H: 0.0%
C: -0.84%
acquisition trial
Medtronic InPen™ Real-World Data and Extended Infusion Set* Pivotal Trial Results Demonstrate Strong Clinical Outcomes and Positive User Experience
Published: 2021-06-28 (Crawled : 17:00) - biospace.com/
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 0.29%
H: 0.1%
C: -1.24%
positive trial trial results
Orange, Sierra Wireless, LACROIX, and STMicroelectronics join forces and launch IoT Continuum to scale up and accelerate the digital transformation of industrial markets
Published: 2021-06-28 (Crawled : 17:00) - globenewswire.com
STM | $38.6 -2.55% 0.0% 4M
|
Electronic Technology
|
| O: 0.11%
H: 1.97%
C: 1.53%
SWIR | $30.99 0.03% 0.0% 0
|
Electronic Technology
|
| O: 0.0%
H: 0.76%
C: -1.12%
electronics iot trial
CNH Industrial announces management changes within Firefighting Business Unit
Published: 2021-06-28 (Crawled : 15:15) - globenewswire.com
CNHI | News | $12.31 -0.73% 0.0% 6.9M
|
Producer Manufacturing
|
| O: 0.06%
H: 0.0%
C: -1.32%
trial
Air Products to Showcase Industrial Gas Solutions with Virtual Booth at AISTech2021
Published: 2021-06-28 (Crawled : 15:00) - prnewswire.com
APD | $231.64 -0.59% 0.0% 1.7M
|
Process Industries
|
| O: 0.37%
H: 0.33%
C: -0.19%
trial
Industrial Floor Coatings Gaining Popularity amid Surging Application in Manufacturing Sector: Fact.MR
Published: 2021-06-28 (Crawled : 14:15) - prnewswire.com
GIC | News | $40.52 0.87% 0.0% 56K
|
Retail Trade
|
| O: 0.19%
H: 0.27%
C: -0.82%
MMM | $92.27 0.86% -0.18% 3.6M
|
Producer Manufacturing
|
| O: 0.52%
H: 0.59%
C: 0.38%
trial application
Atsena Therapeutics Receives Orphan Drug Designation from the FDA for Novel Gene Therapy to Treat Genetic Eye Disease LCA1Phase I/II clinical trial is ongoing in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D
Published: 2021-06-28 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
disease fda genetic ongoing eye gene therapy therapy eye disease drug trial gene therapies designation
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Improved both Primary Cognitive and Secondary MDS-UPDRS Efficacy Endpoints with Significant Biomarker Correlation in Placebo-Controlled Phase 2 Clinical Trial
Published: 2021-06-28 (Crawled : 13:00) - biospace.com/
AVXL | $3.8 0.0% 2.1M
|
Health Technology
|
| O: 20.0%
H: 6.06%
C: -2.83%
phase 2 correlation life science trial anavex®2-73 anavex biomarkers
Lumos Pharma Announces OraGrowtH212 Trial of LUM-201 in PGHD Is Open for Enrollment
Published: 2021-06-28 (Crawled : 12:15) - globenewswire.com
LUMO | News | $2.57 -1.91% -1.95% 12K
|
Health Technology
|
| O: -1.17%
H: 1.18%
C: -0.82%
growth trial enroll pharma
Hoth Therapeutics Announces Positive Safety Results from AD001 Cohort 1 of Phase 1b Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis
Published: 2021-06-28 (Crawled : 12:00) - ir.hoththerapeutics.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 1.26%
H: 4.97%
C: -1.86%
treatment phase 1 positive results dermatitis trial atopic dermatitis phase 1b al001 adi-001 phase 2b
Onconova Therapeutics Provides an Update on the Phase 1/2a Trial of Rigosertib-Nivolumab Combination in KRAS+ Non-Small Cell Lung Cancer
Published: 2021-06-28 (Crawled : 12:00) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: 1.12%
H: 3.46%
C: 2.63%
lung cancer phase 1 cancer trial phase 2 nivolumab
Galera Announces Completion of Enrollment in Pivotal 455-Patient Phase 3 Trial of Avasopasem for Severe Oral Mucositis
Published: 2021-06-28 (Crawled : 12:00) - biospace.com/
GRTX | $0.1833 -1.45% -1.47% 800K
|
Health Technology
|
| O: 2.73%
H: 3.74%
C: 0.59%
phase 3 trial oral mucositis enroll avasopasem
Rockwell Medical, Inc. Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion
Published: 2021-06-28 (Crawled : 12:00) - biospace.com/
RMTI | $1.46 -1.35% -1.37% 82K
|
Health Technology
|
| O: 3.06%
H: 4.26%
C: 2.14%
treatment fda iron deficiency anemia trial
Zentalis Pharmaceuticals Announces Updates Across its Pipeline Including Promising New Interim Clinical Data on ZN-c3 (WEE1i) and ZN-c5 (SERD) and Two Potentially Registrational Trials for ZN-c3, with the First Trial Already Initiated
Published: 2021-06-28 (Crawled : 12:00) - biospace.com/
ZNTL | $12.97 3.43% 3.32% 1M
|
Health Technology
|
| O: 0.1%
H: 2.45%
C: -4.89%
potential trial initiated
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Improved both Primary Cognitive and Secondary MDS-UPDRS Efficacy Endpoints with Significant Biomarker Correlation in Placebo-Controlled Phase 2 Clinical Trial for the Treatment of Patients with Parkinson’s Disease Dementia
Published: 2021-06-28 (Crawled : 12:00) - anavex.com
AVXL | $3.8 0.0% 2.1M
|
Health Technology
|
| O: 20.0%
H: 6.06%
C: -2.83%
disease treatment phase 2 dementia correlation parkinson life science trial anavex®2-73 anavex biomarkers
Precision BioSciences and SpringWorks Therapeutics Dose First Patient in Expanded Phase 1/2a Clinical Trial Evaluating PBCAR269A with Nirogacestat in Patients with Relapsed/Refractory Multiple Myeloma
Published: 2021-06-28 (Crawled : 12:00) - biospace.com/
SWTX | News | $40.075 -5.64% -5.98% 1.4M
|
Health Technology
|
| O: 0.01%
H: 0.85%
C: -2.43%
DTIL | $9.75 -9.05% -9.95% 170K
|
Health Technology
|
| O: 11.94%
H: 0.24%
C: -4.78%
phase 1 trial phase 2
The Industrial Protective Fabrics Market projected to surpass $9650 million by 2027, says Global Market Insights Inc.
Published: 2021-06-28 (Crawled : 10:00) - prnewswire.com
HON | News M | $194.27 1.67% 1.64% 3.6M
|
Producer Manufacturing
|
| O: 0.17%
H: 0.45%
C: -1.06%
trial
Kymera Therapeutics Announces Positive Interim Results from Single Ascending Dose Phase 1 Trial of KT-474 Demonstrating Degrader Proof-of-Mechanism
Published: 2021-06-28 (Crawled : 10:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 2.97%
H: 3.46%
C: 3.24%
phase 1 positive results trial phase 2
Exelixis and Ipsen Announce Cabozantinib in Combination with an Immune Checkpoint Inhibitor Significantly Improved Progression-Free Survival in Phase 3 COSMIC-312 Pivotal Trial in Patients with Previously Untreated Advanced Liver Cancer
Published: 2021-06-28 (Crawled : 09:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.24%
H: 0.03%
C: -0.47%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: -13.27%
H: 2.16%
C: -11.28%
cancer phase 3 liver trial
Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial
Published: 2021-06-28 (Crawled : 08:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
phase 2 phase 2/3 positive results topline trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.